4.7 Article

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range

Jaspal S. Taggar et al.

CURRENT MEDICAL RESEARCH AND OPINION (2008)

Article Cardiac & Cardiovascular Systems

Epidemiology and outcomes in patients with atrial fibrillation in the United States

Alexander M. Walker et al.

HEART RHYTHM (2008)

Review Clinical Neurology

Atrial fibrillation and stroke prevention

Gregory Y. H. Lip et al.

LANCET NEUROLOGY (2007)

Article Cardiac & Cardiovascular Systems

Dabigatran with or without concomitant Aspirin compared with Warfarin alone in patients with nonvalvular atrial fibrillation (PETRO study)

Michael D. Ezekowitz et al.

AMERICAN JOURNAL OF CARDIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation

Seiji Habara et al.

EUROPEAN HEART JOURNAL (2007)

Article Cardiac & Cardiovascular Systems

Challenges of establishing new antithrombotic therapies in atrial fibrillation

Stuart J. Connolly et al.

CIRCULATION (2007)

Article Public, Environmental & Occupational Health

Hepatic findings in long-term clinical trials of ximelagatran

WM Lee et al.

DRUG SAFETY (2005)

Article Critical Care Medicine

The pharmacology and management of the vitamin K antagonists

J Ansell et al.

Article Medicine, General & Internal

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

EM Hylek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)